Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

cervical adenosquamous carcinoma, glassy cell variant - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

cervical adenosquamous carcinoma, glassy cell variant

MONDO:0004542

Also known as:GCC of the cervixglassy cell adenocarcinoma of the uterine cervixglassy cell carcinoma of the cervix

Overview

A poorly differentiated variant of adenosquamous carcinoma that arises from the cervix. It is characterized by the presence of large malignant cells with ground glass cytoplasm and stromal eosinophilic infiltrates.

ResearchLimited published research (4 articles)

Diagnosis

Biomarker and diagnostic research for cervical adenosquamous carcinoma, glassy cell variant has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for cervical adenosquamous carcinoma, glassy cell variant.

4 publications have been identified in PubMed for cervical adenosquamous carcinoma, glassy cell variant. Research spans Review / Meta-Analysis (50%), Diagnostic / Biomarker (25%), and Epidemiology / Natural History (25%).

Recent Publications

Terzioglu HG (2026). [PMID: 41114631](https://pubmed.ncbi.nlm.nih.gov/41114631/). *Diagnostic cytopathology*. [Diagnostic / Biomarker]
Richard TJ (2025). [PMID: 40248265](https://pubmed.ncbi.nlm.nih.gov/40248265/). *Ecancermedicalscience*. [Review / Meta-Analysis]
Obeidat A (2025). [PMID: 40486598](https://pubmed.ncbi.nlm.nih.gov/40486598/). *Annals of medicine and surgery (2012)*. [Epidemiology / Natural History]
Arango-Bravo EA (2024). [PMID: 39007101](https://pubmed.ncbi.nlm.nih.gov/39007101/). *Frontiers in oncology*. [Review / Meta-Analysis]

Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:02 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:213833

GARD

Genetic and Rare Diseases Info Center

GARD:20500

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

cervical adenosquamous carcinoma, glassy cell variant

Overview

Diagnosis

Research Landscape

Recent Publications

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team